))
Setting Up a Robust CGT Supply Chain (Part 2)
Manage episode 435605126 series 3554424
Conteúdo fornecido por Quick Group of Companies. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Quick Group of Companies ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Today we continue our conversation with Mike Sweeney, Global Head of Strategy for Cell & Gene Therapies and Direct to Patient products at QuickSTAT Global Life Science Logistics, on how to set up a robust CGT supply chain.
In Part 1, Mike described the explosion of cell and gene therapies registered for clinical trials – plus the hope and supply chain logistics challenges that growth provides.
In Part 2, Mike discusses the benefits of advanced planning, the role of technology, as well as cold chain and chain of custody. We began, however, with his analysis of the ongoing regulatory change globally. I asked Mike: How does QuickSTAT stay on top of it, and what type of guidance do they give?
6 episódios
Compartilhar
